Transcriptional factor C/EBP was activated through the IL-6 autocrine loop mechanism, causing MDR-1 upregulation and inducing resistance to doxorubicin, vincristine, and taxol in IL-6-expressing mammary carcinoma cells36. This evidence concerns the gene IL6 and breast carcinoma.